Post-exposure anthrax prophylaxis.
D015746:Abdominal Pain / Q000139:chemically induced; D000818:Animals; D000881:Anthrax / Q000517:prevention & control*; D022122:Anthrax Vaccines / Q000008:administration & dosage / Q000600:supply & distribution / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001408:Bacillus anthracis; D002939:Ciprofloxacin / Q000009:adverse effects / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004318:Doxycycline / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004781:Environmental Exposure / Q000517:prevention & control; D000882:Haplorhini; D006801:Humans; D007592:Joint Diseases / Q000139:chemically induced; D007769:Lactams; D009325:Nausea / Q000139:chemically induced; D010406:Penicillins / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000517:prevention & control*; D014611:Vaccination
D022122:Anthrax Vaccines; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D007769:Lactams; D010406:Penicillins; D002939:Ciprofloxacin; D004318:Doxycycline